SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2188687

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2188687

Opioid Analgesics Market Size, Share & Trends Analysis Report By Drug Type (Morphine, Codeine, Oxycodone, Hydrocodone, Hydromorphone), By Application, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Opioid Analgesics Market Summary

The global opioid analgesics market size was valued at USD 26.2 billion in 2025 and is projected to grow from USD 27.2 billion in 2026 to USD 37.1 billion by 2033, at a CAGR of 4.5% from 2026 to 2033. North America dominated the market, accounting for the revenue share of 41.2% in 2025. Opioid analgesics are medicines used to manage moderate to severe pain by acting on opioid receptors in the central nervous system.

The market includes morphine, codeine, oxycodone, hydrocodone, hydromorphone, and other opioid medicines used in pain management. These drugs are prescribed for conditions such as postoperative pain, cancer-related pain, traumatic injuries, and selected chronic pain conditions. Their use depends on pain severity, patient health, treatment history, and clinical guidance. Opioid analgesics are available in oral, parenteral, transdermal, and other formulations to meet different treatment requirements. However, their use requires careful medical assessment because of the risks of respiratory depression, physical dependence, and misuse. These factors influence prescribing practices, product selection, and access to opioid medicines across healthcare systems.

The need for pain management in surgical care, cancer treatment, emergency medicine, and palliative care supports the use of opioid analgesics. Drug selection varies according to the type and severity of pain, the required duration of treatment, and the patient's response to therapy. Morphine and hydromorphone are used in different acute and severe pain conditions, while oxycodone and hydrocodone are prescribed for selected pain indications, subject to local approvals. Codeine also serves as an option for pain relief in eligible patients. Oral formulations support outpatient treatment, while parenteral products are used when injectable administration is required. Transdermal formulations provide sustained drug delivery for selected patients. At the same time, clinical guidelines encourage appropriate prescribing, patient monitoring, and consideration of non-opioid treatments when suitable.

The opioid analgesics industry is shaped by national prescribing regulations, drug safety requirements, healthcare access, and the availability of alternative pain treatments. Controlled-substance status varies by medicine and country, while over-the-counter access is limited to specific products in jurisdictions where regulations permit such use. Hospital pharmacies supply opioid medicines for inpatient care, retail pharmacies dispense outpatient prescriptions, and online pharmacies operate under applicable dispensing and prescription requirements. Demand also varies by application, with acute pain management generally involving short-term treatment, while chronic pain management requires ongoing evaluation of treatment benefits and risks. Regulatory controls, concerns about opioid misuse, and the availability of non-opioid treatments continue to influence prescribing decisions and patient access across healthcare systems.

Global Opioid Analgesics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global opioid analgesics market report based on drug type, application, route of administration. distribution channel, and region:

  • Drug Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Morphine
  • Codeine
  • Oxycodone
  • Hydrocodone
  • Hydromorphone
  • Others
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Acute Pain
  • Chronic Pain
  • Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)
  • Oral
  • Parenteral
  • Transdermal
  • Others
  • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Product Code: GVR-4-68041-058-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Type
    • 1.2.2. Application
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Opioid Analgesics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Opioid Analgesics Market: Drug Type Business Analysis

  • 4.1. Drug Type Market Share, 2025 & 2033
  • 4.2. Drug Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2021 to 2033 (USD Billion)
  • 4.4. Morphine
    • 4.4.1. Morphine Market, 2021 - 2033 (USD Billion)
  • 4.5. Codeine
    • 4.5.1. Codeine Market, 2021 - 2033 (USD Billion)
  • 4.6. Oxycodone
    • 4.6.1. Oxycodone Market, 2021 - 2033 (USD Billion)
  • 4.7. Hydrocodone
    • 4.7.1. Hydrocodone Market, 2021 - 2033 (USD Billion)
  • 4.8. Hydromorphone
    • 4.8.1. Hydromorphone Market, 2021 - 2033 (USD Billion)
  • 4.9. Others
    • 4.9.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 5. Opioid Analgesics Market: Application Business Analysis

  • 5.1. Application Market Share, 2025 & 2033
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Billion)
  • 5.4. Acute Pain
    • 5.4.1. Acute Pain Market, 2021 - 2033 (USD Billion)
  • 5.5. Chronic Pain
    • 5.5.1. Chronic Pain Market, 2021 - 2033 (USD Billion)

Chapter 6. Opioid Analgesics Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2025 & 2033
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion)
  • 6.4. Oral
    • 6.4.1. Oral Market, 2021 - 2033 (USD Billion)
  • 6.5. Parenteral
    • 6.5.1. Parenteral Market, 2021 - 2033 (USD Billion)
  • 6.6. Transdermal
    • 6.6.1. Transdermal Market, 2021 - 2033 (USD Billion)
  • 6.7. Others
    • 6.7.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 7. Opioid Analgesics Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2025 & 2033
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.5. Retail Pharmacies
    • 7.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 8. Opioid Analgesics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Opioid Analgesics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Reimbursement Framework
      • 8.4.2.4. U.S. Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Reimbursement Framework
      • 8.4.3.4. Canada Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Reimbursement Framework
      • 8.4.4.4. Mexico Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5. Europe
    • 8.5.1. Europe Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Reimbursement Framework
      • 8.5.2.4. UK Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Reimbursement Framework
      • 8.5.3.4. Germany Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Reimbursement Framework
      • 8.5.4.4. France Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Reimbursement Framework
      • 8.5.5.4. Italy Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Reimbursement Framework
      • 8.5.6.4. Spain Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Reimbursement Framework
      • 8.5.7.4. Denmark Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Reimbursement Framework
      • 8.5.8.4. Sweden Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Reimbursement Framework
      • 8.5.9.4. Norway Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Reimbursement Framework
      • 8.6.2.4. Japan Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Reimbursement Framework
      • 8.6.3.4. China Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Reimbursement Framework
      • 8.6.4.4. India Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Reimbursement Framework
      • 8.6.5.4. Australia Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Reimbursement Framework
      • 8.6.6.4. South Korea Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Reimbursement Framework
      • 8.6.7.4. Thailand Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Latin America Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Reimbursement Framework
      • 8.7.2.4. Brazil Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Reimbursement Framework
      • 8.7.3.4. Argentina Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Reimbursement Framework
      • 8.8.2.4. South Africa Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Reimbursement Framework
      • 8.8.3.4. Saudi Arabia Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Reimbursement Framework
      • 8.8.4.4. UAE Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Reimbursement Framework
      • 8.8.5.4. Kuwait Opioid Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Teva Pharmaceutical Industries Ltd.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Pfizer Inc.
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Hikma Pharmaceuticals plc
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Mallinckrodt plc
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Collegium Pharmaceutical, Inc.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Grunenthal GmbH
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Mundipharma International Limited
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Purdue Pharma L.P.
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Amneal Pharmaceuticals, Inc.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Viatris Inc.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
Product Code: GVR-4-68041-058-4

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Opioid Analgesics Market, By Region, 2021 - 2033 (USD Billion)
  • Table 4 Global Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 5 Global Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 6 Global Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 7 Global Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 8 North America Opioid Analgesics Market, By Country, 2021 - 2033 (USD Billion)
  • Table 9 North America Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 10 North America Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 11 North America Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 12 North America Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 13 U.S. Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 14 U.S. Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 15 U.S. Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 16 U.S. Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 17 Canada Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 18 Canada Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 19 Canada Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 20 Canada Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 21 Mexico Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 22 Mexico Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 23 Mexico Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 24 Mexico Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 25 Europe Opioid Analgesics Market, By Country, 2021 - 2033 (USD Billion)
  • Table 26 Europe Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 27 Europe Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 28 Europe Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 29 Europe Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 30 UK Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 31 UK Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 32 UK Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 33 UK Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 34 Germany Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 35 Germany Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 36 Germany Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 37 Germany Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 38 France Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 39 France Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 40 France Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 41 France Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 42 Italy Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 43 Italy Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 44 Italy Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 45 Italy Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 46 Spain Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 47 Spain Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 48 Spain Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 49 Spain Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 50 Norway Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 51 Norway Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 52 Norway Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 53 Norway Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 54 Denmark Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 55 Denmark Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 56 Denmark Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 57 Denmark Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 58 Sweden Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 59 Sweden Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 60 Sweden Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 61 Sweden Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 62 Asia Pacific Opioid Analgesics Market, By Country, 2021 - 2033 (USD Billion)
  • Table 63 Asia Pacific Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 64 Asia Pacific Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 65 Asia Pacific Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 66 Asia Pacific Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 67 Japan Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 68 Japan Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 69 Japan Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 70 Japan Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 71 China Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 72 China Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 73 China Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 74 China Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 75 India Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 76 India Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 77 India Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 78 India Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 79 Australia Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 80 Australia Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 81 Australia Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 82 Australia Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 83 South Korea Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 84 South Korea Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 85 South Korea Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 86 South Korea Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 87 Thailand Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 88 Thailand Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 89 Thailand Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 90 Thailand Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 91 Latin America Opioid Analgesics Market, By Country, 2021 - 2033 (USD Billion)
  • Table 92 Latin America Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 93 Latin America Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 94 Latin America Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 95 Latin America Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 96 Brazil Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 97 Brazil Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 98 Brazil Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 99 Brazil Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 100 Argentina Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 101 Argentina Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 102 Argentina Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 103 Argentina Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 104 Middle East & Africa Opioid Analgesics Market, By Country, 2021 - 2033 (USD Billion)
  • Table 105 Middle East & Africa Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 106 Middle East & Africa Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 107 Middle East & Africa Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 108 Middle East & Africa Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 109 South Africa Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 110 South Africa Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 111 South Africa Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 112 South Africa Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 113 Saudi Arabia Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 114 Saudi Arabia Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 115 Saudi Arabia Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 116 Saudi Arabia Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 117 UAE Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 118 UAE Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 119 UAE Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 120 UAE Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
  • Table 121 Kuwait Opioid Analgesics Market, By Drug Type, 2021 - 2033 (USD Billion)
  • Table 122 Kuwait Opioid Analgesics Market, By Application, 2021 - 2033 (USD Billion)
  • Table 123 Kuwait Opioid Analgesics Market, By Route of Administration, 2021 - 2033 (USD Billion)
  • Table 124 Kuwait Opioid Analgesics Market, By Distribution Channel, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Opioid Analgesics Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Competitive Landscape
  • Fig. 10 Opioid Analgesics Market Dynamics
  • Fig. 11 Opioid Analgesics Market: Porter's Five Forces Analysis
  • Fig. 12 Opioid Analgesics Market: PESTLE Analysis
  • Fig. 13 Drug Type Market, 2021 - 2033 (USD Billion)
  • Fig. 14 Morphine Market, 2021 - 2033 (USD Billion)
  • Fig. 15 Codeine Market, 2021 - 2033 (USD Billion)
  • Fig. 16 Oxycodone Market, 2021 - 2033 (USD Billion)
  • Fig. 17 Hydrocodone Market, 2021 - 2033 (USD Billion)
  • Fig. 18 Hydromorphone Market, 2021 - 2033 (USD Billion)
  • Fig. 19 Others Market, 2021 - 2033 (USD Billion)
  • Fig. 20 Application Market, 2021 - 2033 (USD Billion)
  • Fig. 21 Acute Pain Market, 2021 - 2033 (USD Billion)
  • Fig. 22 Chronic Pain Market, 2021 - 2033 (USD Billion)
  • Fig. 23 Route of Administration Market, 2021 - 2033 (USD Billion)
  • Fig. 24 Oral Market, 2021 - 2033 (USD Billion)
  • Fig. 25 Parenteral Market, 2021 - 2033 (USD Billion)
  • Fig. 26 Transdermal Market, 2021 - 2033 (USD Billion)
  • Fig. 27 Others Market, 2021 - 2033 (USD Billion)
  • Fig. 28 Distribution Channel Market, 2021 - 2033 (USD Billion)
  • Fig. 29 Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
  • Fig. 30 Retail Pharmacies Market, 2021 - 2033 (USD Billion)
  • Fig. 31 Others Market, 2021 - 2033 (USD Billion)
  • Fig. 32 Opioid Analgesics Market Revenue, By Region
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 North America Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 35 U.S. Country Dynamics
  • Fig. 36 U.S. Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 37 Canada Country Dynamics
  • Fig. 38 Canada Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 39 Mexico Country Dynamics
  • Fig. 40 Mexico Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 41 Europe Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 42 UK Country Dynamics
  • Fig. 43 UK Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 44 Germany Country Dynamics
  • Fig. 45 Germany Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 46 France Country Dynamics
  • Fig. 47 France Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 48 Italy Country Dynamics
  • Fig. 49 Italy Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 50 Spain Country Dynamics
  • Fig. 51 Spain Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 52 Norway Country Dynamics
  • Fig. 53 Norway Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 54 Sweden Country Dynamics
  • Fig. 55 Sweden Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 56 Denmark Country Dynamics
  • Fig. 57 Denmark Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 58 Asia Pacific Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 59 Japan Country Dynamics
  • Fig. 60 Japan Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 61 China Country Dynamics
  • Fig. 62 China Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 63 India Country Dynamics
  • Fig. 64 India Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 65 Australia Country Dynamics
  • Fig. 66 Australia Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 67 South Korea Country Dynamics
  • Fig. 68 South Korea Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 69 Thailand Country Dynamics
  • Fig. 70 Thailand Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 71 Latin America Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 72 Brazil Country Dynamics
  • Fig. 73 Brazil Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 74 Argentina Country Dynamics
  • Fig. 75 Argentina Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 76 MEA Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 77 South Africa Country Dynamics
  • Fig. 78 South Africa Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 79 Saudi Arabia Country Dynamics
  • Fig. 80 Saudi Arabia Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 81 UAE Country Dynamics
  • Fig. 82 UAE Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 83 Kuwait Country Dynamics
  • Fig. 84 Kuwait Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 85 Company Categorization
  • Fig. 86 Company Market Position Analysis
  • Fig. 87 Strategic Framework
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!